Guangzhou Jet Bio-Filtration (688026.SH): The fundraising project "Intelligent Manufacturing Project for Upgrading the Biological Laboratory Consumables Production Line" has been postponed until December 2026.

Gelonghui, December 30 | Guangzhou Jet Bio-Filtration (688026.SH) announced that the company held the sixteenth meeting of the fourth Board of Directors and the ninth meeting of the fourth Supervisory Board on December 30, 2024, during which it reviewed and approved the proposal on the postponement of certain fundraising investment projects, agreeing to extend the expected usable status of the fundraising project "Intelligent Manufacturing project for upgrading biological laboratory consumables production line" to December 2026, and the expected usable status of the fundraising project "Research and development project for new biological laboratory consumables" to December 2025.

Gelonghui FinanceDec 30, 2024 16:50

Guangzhou Jet Bio-Filtration (688026.SH): Plans to use no more than 0.2 billion yuan of idle raised funds to temporarily supplement working capital.

On December 30, 2023, Guangzhou Jet Bio-Filtration (688026.SH) announced that it held the sixteenth meeting of the fourth Board of Directors and the ninth meeting of the fourth Supervisory Board. They reviewed and approved the proposal on the temporary use of part of the idle raised funds to supplement working capital, agreeing to use no more than 200 million yuan (including 200 million yuan) of idle raised funds temporarily to supplement working capital for production and operation activities related to the company's main business. The usage period shall not exceed 12 months from the date of approval by the Board of Directors, and the above amount is valid within this period.

Gelonghui FinanceDec 30, 2024 16:49

guangzhou jet bio-filtration (688026): Profit in Q3 2024 increased year-on-year, with continuous recovery in downstream demand.

Event: On October 24, 2024, guangzhou jet bio-filtration released the third quarter report of 2024: The company achieved revenue of 0.391 billion yuan in the first three quarters of 2024, an 18.56% increase year-on-year; Achieved a net income attributable to the parent of 0.

sealand securitiesOct 25, 2024 15:42

Jet Biotech: Third quarter report 2024

SZSIOct 24, 2024 00:00 · Announcements

Third Quarter Report 2024

SZSIOct 24, 2024 00:00 · Announcements

guangzhou jet bio-filtration (688026.SH): net income of 50.1568 million yuan in the first three quarters, a year-on-year increase of 259.26%

Guangzhou Jet Bio-filtration (688026.SH) announced on October 23 that the company's revenue for the first three quarters was 0.391 billion yuan, an 18.56% year-on-year increase; net income attributable to shareholders of the listed company was 50.1568 million yuan, a 259.26% year-on-year increase; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 44.0412 million yuan, a 330.98% year-on-year increase; basic earnings per share was 0.41 yuan.

Gelonghui FinanceOct 23, 2024 17:51